ClinicalTrials.gov
public full text
Public Domain
Glucocorticoid on the Prognosis of TEVAR
To explore the potential prognostic effect of glucocorticoid on the postoperative aorta-related adverse events after aortic dissections patients underwent thoracic endovascular aortic repair (TEVAR), glucocorticoid (30mg/kg) will be intravenously given within 2h after TEVAR.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Conventional TEVAR Versus FABULOUS RCT#1059758
- Perioperative Eosinophils Their Recovery in Type A Acute Aortic Dissection Prognosis#907423
- Temporal Artery Biopsy vs ULtrasound in Diagnosis of GCA (TABUL)#1128323
- Prospective Randomized Trial Comparing THD Versus Stapler Operation for 3rd Degree Hemorrhoids#1164299
- Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis#851366
Record · ID 896304
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive